Aarhus Universitets segl

Pernille Tine Jensen

Quality of life characteristics inpatients with cervical cancer

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Quality of life characteristics inpatients with cervical cancer. / Bjelic-Radisic, Vesna; Jensen, Pernille T; Vlasic, Karin Kuljanic et al.

I: European Journal of Cancer, Bind 48, Nr. 16, 2012, s. 3009-18.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Bjelic-Radisic, V, Jensen, PT, Vlasic, KK, Waldenstrom, A-C, Singer, S, Chie, W, Nordin, A & Greimel, E 2012, 'Quality of life characteristics inpatients with cervical cancer', European Journal of Cancer, bind 48, nr. 16, s. 3009-18. https://doi.org/10.1016/j.ejca.2012.05.011

APA

Bjelic-Radisic, V., Jensen, P. T., Vlasic, K. K., Waldenstrom, A-C., Singer, S., Chie, W., Nordin, A., & Greimel, E. (2012). Quality of life characteristics inpatients with cervical cancer. European Journal of Cancer, 48(16), 3009-18. https://doi.org/10.1016/j.ejca.2012.05.011

CBE

Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom A-C, Singer S, Chie W, Nordin A, Greimel E. 2012. Quality of life characteristics inpatients with cervical cancer. European Journal of Cancer. 48(16):3009-18. https://doi.org/10.1016/j.ejca.2012.05.011

MLA

Bjelic-Radisic, Vesna et al. "Quality of life characteristics inpatients with cervical cancer". European Journal of Cancer. 2012, 48(16). 3009-18. https://doi.org/10.1016/j.ejca.2012.05.011

Vancouver

Bjelic-Radisic V, Jensen PT, Vlasic KK, Waldenstrom A-C, Singer S, Chie W et al. Quality of life characteristics inpatients with cervical cancer. European Journal of Cancer. 2012;48(16):3009-18. https://doi.org/10.1016/j.ejca.2012.05.011

Author

Bjelic-Radisic, Vesna ; Jensen, Pernille T ; Vlasic, Karin Kuljanic et al. / Quality of life characteristics inpatients with cervical cancer. I: European Journal of Cancer. 2012 ; Bind 48, Nr. 16. s. 3009-18.

Bibtex

@article{b8d6f3cb000e4654a432a74ef8f8c133,
title = "Quality of life characteristics inpatients with cervical cancer",
abstract = "AIM: Annually about 500,000 women worldwide are diagnosed with cervical cancer. For many patients, young age at the time of diagnosis and a good prognosis regarding the disease imply a long life with the side-effects and sequels of various treatment options. The present study investigated the extent to which different quality of life (QoL) domains in patients during and after treatment for cervical cancer are affected according to menopausal status, treatment status and treatment modality. METHODS: QoL data from 346 cervical cancer patients from 14 countries who were included in a cervical cancer module validation study of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Group were analysed according to menopausal status, treatment status and treatment modality. QOL was assessed using the EORTC Quality of life Questionnaire (QLQ)-C30 and the QLQ-CX24 module. Statistical analyses were performed using descriptive statistics and analysis of covariance. RESULTS: Active treatment had the strongest negative impact on 13 different QoL domains: physical, role, emotional, cognitive, social functioning, global health/QoL, fatigue, nausea and emesis, pain, appetite loss, constipation, symptom experience and sexual enjoyment. Irradiation alone±other therapy was associated with most symptoms of diarrhoea. Age had the most negative impact on sexual activity and the strongest positive effect on sexual worry. CONCLUSION: Our results revealed that patients with cervical carcinoma had different side-effects with different impacts on QOL depending on the menopausal status and therapy modalities. Patients should be informed about the possibility that therapy may have a negative impact on QoL.",
author = "Vesna Bjelic-Radisic and Jensen, {Pernille T} and Vlasic, {Karin Kuljanic} and Ann-Charlotte Waldenstrom and Susanne Singer and Weichu Chie and Andy Nordin and Elfriede Greimel",
note = "Copyright {\textcopyright} 2012 Elsevier Ltd. All rights reserved.",
year = "2012",
doi = "10.1016/j.ejca.2012.05.011",
language = "English",
volume = "48",
pages = "3009--18",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Pergamon",
number = "16",

}

RIS

TY - JOUR

T1 - Quality of life characteristics inpatients with cervical cancer

AU - Bjelic-Radisic, Vesna

AU - Jensen, Pernille T

AU - Vlasic, Karin Kuljanic

AU - Waldenstrom, Ann-Charlotte

AU - Singer, Susanne

AU - Chie, Weichu

AU - Nordin, Andy

AU - Greimel, Elfriede

N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.

PY - 2012

Y1 - 2012

N2 - AIM: Annually about 500,000 women worldwide are diagnosed with cervical cancer. For many patients, young age at the time of diagnosis and a good prognosis regarding the disease imply a long life with the side-effects and sequels of various treatment options. The present study investigated the extent to which different quality of life (QoL) domains in patients during and after treatment for cervical cancer are affected according to menopausal status, treatment status and treatment modality. METHODS: QoL data from 346 cervical cancer patients from 14 countries who were included in a cervical cancer module validation study of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Group were analysed according to menopausal status, treatment status and treatment modality. QOL was assessed using the EORTC Quality of life Questionnaire (QLQ)-C30 and the QLQ-CX24 module. Statistical analyses were performed using descriptive statistics and analysis of covariance. RESULTS: Active treatment had the strongest negative impact on 13 different QoL domains: physical, role, emotional, cognitive, social functioning, global health/QoL, fatigue, nausea and emesis, pain, appetite loss, constipation, symptom experience and sexual enjoyment. Irradiation alone±other therapy was associated with most symptoms of diarrhoea. Age had the most negative impact on sexual activity and the strongest positive effect on sexual worry. CONCLUSION: Our results revealed that patients with cervical carcinoma had different side-effects with different impacts on QOL depending on the menopausal status and therapy modalities. Patients should be informed about the possibility that therapy may have a negative impact on QoL.

AB - AIM: Annually about 500,000 women worldwide are diagnosed with cervical cancer. For many patients, young age at the time of diagnosis and a good prognosis regarding the disease imply a long life with the side-effects and sequels of various treatment options. The present study investigated the extent to which different quality of life (QoL) domains in patients during and after treatment for cervical cancer are affected according to menopausal status, treatment status and treatment modality. METHODS: QoL data from 346 cervical cancer patients from 14 countries who were included in a cervical cancer module validation study of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Group were analysed according to menopausal status, treatment status and treatment modality. QOL was assessed using the EORTC Quality of life Questionnaire (QLQ)-C30 and the QLQ-CX24 module. Statistical analyses were performed using descriptive statistics and analysis of covariance. RESULTS: Active treatment had the strongest negative impact on 13 different QoL domains: physical, role, emotional, cognitive, social functioning, global health/QoL, fatigue, nausea and emesis, pain, appetite loss, constipation, symptom experience and sexual enjoyment. Irradiation alone±other therapy was associated with most symptoms of diarrhoea. Age had the most negative impact on sexual activity and the strongest positive effect on sexual worry. CONCLUSION: Our results revealed that patients with cervical carcinoma had different side-effects with different impacts on QOL depending on the menopausal status and therapy modalities. Patients should be informed about the possibility that therapy may have a negative impact on QoL.

U2 - 10.1016/j.ejca.2012.05.011

DO - 10.1016/j.ejca.2012.05.011

M3 - Journal article

C2 - 22683166

VL - 48

SP - 3009

EP - 3018

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 16

ER -